Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs JetBlue Airways Corporation (JBLU) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs JetBlue Airways Corporation — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $69 (market cap $30.93B), while JetBlue Airways Corporation trades at $3.02 (market cap $1.13B). The key difference: GE HealthCare Technologies Inc. Common Stock is far larger — about 27.4× JetBlue Airways Corporation's market cap, and GE HealthCare Technologies Inc. Common Stock pays a 0.23% dividend while JetBlue Airways Corporation pays none. Which is the better fit depends on your goals.
| GEHC | JBLU | |
|---|---|---|
Market Cap | $30.93B | $1.13B |
Volume | 5,033,451 | 40,474,891 |
Sector | Health | Industrials |
52-Week High | $88.16 | $6.46 |
52-Week Low | $59.48 | $3.01 |
Enterprise Value | $39.39B | $8.50B |
Dividend Yield | 0.23% | — |
Typical Hold Time | — | 44 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
JetBlue (JBLU) trades at $3.35, down 7.46% today, reflecting persistent bearish sentiment amid negative earnings and high debt. The technical outlook is bearish with key support at $3, while fundamentals show revenue near $9.1B but net losses widening, with a negative ROE of -44.36%. Recent news includes route expansion in Colombia but also capacity cuts and elevated fuel costs pressuring margins.
The stock faces significant headwinds from consecutive quarterly losses and rising leverage, yet analyst consensus suggests a $5.89 price target implies potential upside if cost controls improve. Key risks include volatile fuel prices, competitive pressures, and execution of the JetForward strategy amidst a challenging macroeconomic backdrop for airlines.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About JetBlue Airways Corporation
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It carries over millions of customers with an average of more than 1,000 daily flights and served approximately 99 destinations in the United States, the Caribbean, and Latin America. The company currently operates Airbus A321, Airbus A320, and Embraer E190 aircraft types.
Read more on JBLU →
